Literature DB >> 14644417

The effects of post-translational processing on dystroglycan synthesis and trafficking.

Chris T Esapa1, Graham R B Bentham, Jörn E Schröder, Stephan Kröger, Derek J Blake.   

Abstract

Dystroglycan is a component of the dystrophin glycoprotein complex that is cleaved into two polypeptides by an unidentified protease. To determine the role of post-translational processing on dystroglycan synthesis and trafficking we expressed the dystroglycan precursor and mutants thereof in a heterologous system. A point mutant in the processing site, S655A, prevented proteolytic cleavage but had no effect upon the surface localisation of dystroglycan. Mutation of two N-linked glycosylation sites that flank the cleavage site inhibited proteolytic processing of the precursor. Furthermore, chemical inhibition of N- and O-linked glycosylation interfered with the processing of the precursor and reduced the levels of dystroglycan at the cell surface. Dystroglycan processing was also inhibited by the proteasome inhibitor lactacystin. N-linked glycosylation is a prerequisite for efficient proteolytic processing and cleavage and glycosylation are dispensable for cell surface targeting of dystroglycan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644417     DOI: 10.1016/s0014-5793(03)01230-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

2.  Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality.

Authors:  Tobias Willer; Belén Prados; Juan Manuel Falcón-Pérez; Ingrid Renner-Müller; Gerhard K H Przemeck; Mark Lommel; Antonio Coloma; M Carmen Valero; Martin Hrabé de Angelis; Widmar Tanner; Eckhard Wolf; Sabine Strahl; Jesús Cruces
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

3.  Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.

Authors:  Stefano Gastaldello; Simona D'Angelo; Susanna Franzoso; Marina Fanin; Corrado Angelini; Romeo Betto; Dorianna Sandonà
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

4.  The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent.

Authors:  Richard Milner; Stephanie Hung; Xiaoyun Wang; Maria Spatz; Gregory J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2007-11-21       Impact factor: 6.200

Review 5.  Dystroglycan glycosylation and muscular dystrophy.

Authors:  Christopher J Moore; Jane E Hewitt
Journal:  Glycoconj J       Date:  2008-09-05       Impact factor: 2.916

6.  A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.

Authors:  Cecilia Jimenez-Mallebrera; Silvia Torelli; Lucy Feng; Jihee Kim; Caroline Godfrey; Emma Clement; Rachael Mein; Stephen Abbs; Susan C Brown; Kevin P Campbell; Stephan Kröger; Beril Talim; Haluk Topaloglu; Ros Quinlivan; Helen Roper; Anne M Childs; Maria Kinali; Caroline A Sewry; Francesco Muntoni
Journal:  Brain Pathol       Date:  2008-08-07       Impact factor: 6.508

7.  Dystroglycan is associated to the disulfide isomerase ERp57.

Authors:  Francesca Sciandra; Emanuela Angelucci; Fabio Altieri; Daniela Ricci; Wolfgang Hübner; Tamara C Petrucci; Bruno Giardina; Andrea Brancaccio; Manuela Bozzi
Journal:  Exp Cell Res       Date:  2012-07-16       Impact factor: 3.905

8.  Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2.

Authors:  Hafsa Mamsa; Rachelle L Stark; Kara M Shin; Aaron M Beedle; Rachelle H Crosbie
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

9.  High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding.

Authors:  Paula V Cabrera; Mabel Pang; Jamie L Marshall; Raymond Kung; Stanley F Nelson; Stephanie H Stalnaker; Lance Wells; Rachelle H Crosbie-Watson; Linda G Baum
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

Review 10.  A molecular overview of the primary dystroglycanopathies.

Authors:  Andrea Brancaccio
Journal:  J Cell Mol Med       Date:  2019-03-05       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.